Company & Sponsor Intelligence
Dart NeuroScience, LLC
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed1
Countries2
Therapeutic footprint
other_neurologyout_of_scopestroke
Indexed studies
NCT00758446Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis
out_of_scope · SwedenPHASE2
out_of_scope · SwedenPHASE2
NCT01215552Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712
other_neurology · United StatesPHASE1
other_neurology · United StatesPHASE1
NCT02530307HT-3951 vs. Placebo in Stroke Rehabilitation
stroke · United StatesPHASE2
stroke · United StatesPHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →